In summary, these results illustrate the dependence of NKX2–1 expressing cells on the serine/glycine synthesis pathway for nucleotide metabolism and highlight these processes as promising therapeutic targets in NKX2–1-driven cancers. Here, NKX2-1 is linked to cancer.